BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 35099555)

  • 21. Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease.
    Zhu M; Xu X; Feng Q; Cui Z; Wang T; Yan Y; Ran Z
    Dig Dis Sci; 2021 May; 66(5):1658-1668. PubMed ID: 32524415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Phase I Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Pediatric Perianal Fistulizing Crohn's Disease.
    Lightner AL; Otero-Pineiro A; Reese J; Ream J; Nachand D; Adams AC; VanDenBossche A; Kurowski JA
    Inflamm Bowel Dis; 2023 Dec; 29(12):1912-1919. PubMed ID: 37263018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and MRI Evolution After Local Injection of Bone Marrow-Derived Mesenchymal Stem Cells in Perianal Fistulae in Crohn's Disease: Results From a Prospective Monocentric Study.
    Reenaers C; Gillard RP; Coimbra C; Gillard RM; Meunier P; Lechanteur C; Baudoux E; Boutaffala L; Beguin Y; Louis É
    J Crohns Colitis; 2023 May; 17(5):728-737. PubMed ID: 36733215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesenchymal stem cell therapy for therapy refractory complex Crohn's perianal fistulas: a case series.
    Pronk AJM; Beek KJ; Wildenberg ME; Bemelman WA; Stoker J; Buskens CJ
    Stem Cell Res Ther; 2024 Jun; 15(1):161. PubMed ID: 38853278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogenic stem cells for Crohn's anal fistulas: Treating early improves the deep remission rate.
    Fathallah N; Siproudhis L; Akaffou M; Haouari MA; Landemaine A; Pommaret E; Spindler L; Brochard C; Bouguen G; de Parades V
    Colorectal Dis; 2023 Nov; 25(11):2170-2176. PubMed ID: 37849054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burden and outcomes for complex perianal fistulas in Crohn's disease: Systematic review.
    Panes J; Reinisch W; Rupniewska E; Khan S; Forns J; Khalid JM; Bojic D; Patel H
    World J Gastroenterol; 2018 Nov; 24(42):4821-4834. PubMed ID: 30479468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn's disease.
    Bislenghi G; Wolthuis A; Van Assche G; Vermeire S; Ferrante M; D'Hoore A
    Expert Opin Biol Ther; 2019 Jul; 19(7):607-616. PubMed ID: 31121104
    [No Abstract]   [Full Text] [Related]  

  • 28. Mesenchymal stem cells for the treatment of complex perianal fistulas in patients with Crohn disease.
    Borycka-Kiciak K; Pietrzak A; Kielar M; Tarnowski W
    Pol Przegl Chir; 2019 Jun; 92(1):38-47. PubMed ID: 32312921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights into treatment of complex Crohn's perianal fistulas.
    Norčič G; Smrekar N; Marković S; Barišić G; Kiudelis G; Paužas H; Molnár T; Szijarto A; Šerclová Z; Roblek T; Uršič V; White I
    BMC Proc; 2024 Apr; 18(Suppl 7):7. PubMed ID: 38658942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn's disease: a pilot study.
    Tonelli F; Giudici F; Asteria CR
    Dis Colon Rectum; 2012 Aug; 55(8):870-5. PubMed ID: 22810472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease.
    Molendijk I; Bonsing BA; Roelofs H; Peeters KC; Wasser MN; Dijkstra G; van der Woude CJ; Duijvestein M; Veenendaal RA; Zwaginga JJ; Verspaget HW; Fibbe WE; van der Meulen-de Jong AE; Hommes DW
    Gastroenterology; 2015 Oct; 149(4):918-27.e6. PubMed ID: 26116801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment effect of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of fistulizing Crohn's disease are durable at 12 months.
    Lightner AL; Pineiro AO; Reese J; Ream J; Nachand D; Adams AC; Dadgar N; Hull T
    Surgery; 2024 Apr; 175(4):984-990. PubMed ID: 38097485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of allogeneic umbilical cord-derived mesenchymal stem cells for the treatment of complex perianal fistula in Crohn's disease: a pilot study.
    Wei J; Zhang Y; Chen C; Feng X; Yang Z; Feng J; Jiang Q; Fu J; Xuan J; Gao H; Liao L; Wang F
    Stem Cell Res Ther; 2023 Oct; 14(1):311. PubMed ID: 37904247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deep remission improves the quality of life of patients with Crohn's disease and anoperineal fistula treated with darvadstrocel: results of a French pilot study.
    Fathallah N; Akaffou M; Haouari MA; Spindler L; Alam A; Barré A; Pommaret E; Fels A; de Parades V
    Tech Coloproctol; 2023 Dec; 27(12):1201-1210. PubMed ID: 36811811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrosis and MAGNIFI-CD Activity Index at Magnetic Resonance Imaging to Predict Treatment Outcome in Perianal Fistulizing Crohn's Disease Patients.
    van Rijn KL; Meima-van Praag EM; Bossuyt PM; D'Haens GR; Gecse KB; Horsthuis K; Snijder HJ; Tielbeek JAW; Buskens CJ; Stoker J
    J Crohns Colitis; 2022 Jun; 16(5):708-716. PubMed ID: 34644395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-year outcome of local injection of autologous stromal vascular fraction cells and microfat in refractory perianal fistulas of Crohn's disease.
    Guillo L; Grimaud F; Houser F; Prost C; Jouve E; Philandrianos C; Abellan M; Veran J; Visee C; Beyer-Berjot L; Desjeux A; Dignat-George F; Leone M; Grimaud JC; Sabatier F; Serrero M; Magalon J
    Stem Cell Res Ther; 2022 Feb; 13(1):67. PubMed ID: 35139888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
    Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.
    Topstad DR; Panaccione R; Heine JA; Johnson DR; MacLean AR; Buie WD
    Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modern Treatments and Stem Cell Therapies for Perianal Crohn's Fistulas.
    Al-Maawali AK; Nguyen P; Phang PT
    Can J Gastroenterol Hepatol; 2016; 2016():1651570. PubMed ID: 28053967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis on the efficacy of dual vein induction therapy of Ustekinumab in complex perianal fistulizing Crohn's disease].
    Zhang DL; Shao XX; Hu DY; Lin DP; Wu H; Jiang Y
    Zhonghua Yi Xue Za Zhi; 2023 Nov; 103(41):3301-3306. PubMed ID: 37926575
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.